Immunoprecipitation methods impact the peptide repertoire in immunopeptidomics

IntroductionMass spectrometry-based immunopeptidomics is the only unbiased method to identify naturally presented HLA ligands, which is an indispensable prerequisite for characterizing novel tumor antigens for immunotherapeutic approaches. In recent years, improvements based on devices and methodolo...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:	Frontiers in Immunology
المؤلفون الرئيسيون:	Marcel Wacker, Jens Bauer, Laura Wessling, Marissa Dubbelaar, Annika Nelde, Hans-Georg Rammensee, Juliane S. Walz
التنسيق:	مقال
اللغة:	الإنجليزية
منشور في:	Frontiers Media S.A. 2023-07-01
الموضوعات:	immunotherapies HLA peptides mass spectrometry immunopeptidomics immunoprecipitation hydrophobicity
الوصول للمادة أونلاين:	https://www.frontiersin.org/articles/10.3389/fimmu.2023.1219720/full

مواد مشابهة

872 Combined multi-omics analysis delineates the impact of epigenetic therapies on the immunopeptidome of acute myeloid leukemia
حسب: Hans-Georg Rammensee, وآخرون
منشور في: (2023-11-01)

Warehouse-based, immunopeptidome-guided design of personalised peptide vaccines shows feasibility in clinical trial evaluation in CLL patients
حسب: Jonas S. Heitmann, وآخرون
منشور في: (2024-11-01)

TAPBPR promotes editing of the HLA-B44 peptide repertoire, increasing the presentation of peptides containing a C-terminal tryptophan
حسب: Aure Aflalo, وآخرون
منشور في: (2025-10-01)

MHCquant2 refines immunopeptidomics tumor antigen discovery
حسب: Jonas Scheid, وآخرون
منشور في: (2025-09-01)

1463 The intra-tumoral spatial heterogeneity of T cell antigens in glioblastoma: An integrated multi-omics approach
حسب: Michael Weller, وآخرون
منشور في: (2023-11-01)

PCI-DB: a novel primary tissue immunopeptidome database to guide next-generation peptide-based immunotherapy development
حسب: Sven Nahnsen, وآخرون
منشور في: (2025-04-01)

Reanalysis of Immunopeptidomics Datasets Provides Mechanistic Insight into TAPBPR-Mediated Peptide Editing on HLA-A, -B and -C Molecules [version 1; peer review: 1 approved, 2 approved with reservations]
حسب: Jack L Morley, وآخرون
منشور في: (2024-03-01)

TOFIMS mass spectrometry-based immunopeptidomics refines tumor antigen identification
حسب: Naomi Hoenisch Gravel, وآخرون
منشور في: (2023-11-01)

Long-Term Follow-Up of COVID-19 Convalescents—Immune Response Associated with Reinfection Rate and Symptoms
حسب: Anna Seller, وآخرون
منشور في: (2023-10-01)

P480: DNMT AND HDAC INHIBITION INDUCES IMMUNOGENIC NEOANTIGENS FROM HUMAN ENDOGENOUS RETROVIRAL ELEMENT-DERIVED TRANSCRIPTS
حسب: Ashish Goyal, وآخرون
منشور في: (2023-08-01)

213 Immunopeptidomics of small cell lung cancer reveals numerous tumor-specific HLA ligands as T cell antigen candidates
حسب: Julie George, وآخرون
منشور في: (2023-11-01)

The oncogenic fusion protein DNAJB1-PRKACA can be specifically targeted by peptide-based immunotherapy in fibrolamellar hepatocellular carcinoma
حسب: Jens Bauer, وآخرون
منشور في: (2022-10-01)

Elevated SARS-CoV-2-Specific Antibody Levels in Patients with Post-COVID Syndrome
حسب: Christopher Hackenbruch, وآخرون
منشور في: (2023-03-01)

SAPrIm 2.0: a semi-automated protocol for mid-throughput soluble HLA immunopeptidomics
حسب: Erwin Tanuwidjaya, وآخرون
منشور في: (2025-04-01)

Identification and relative abundance of naturally presented and cross-reactive influenza A virus MHC class I-restricted T cell epitopes
حسب: Hazem Hamza, وآخرون
منشور في: (2024-12-01)

Multi-omics analysis of overexpressed tumor-associated proteins: gene expression, immunopeptide presentation, and antibody response in oropharyngeal squamous cell carcinoma, with a focus on cancer-testis antigens
حسب: Tsima Abou Kors, وآخرون
منشور في: (2024-07-01)

iVAC-XS15-CLL01: personalized multi-peptide vaccination in combination with the TLR1/2 ligand XS15 in CLL patients undergoing BTK-inhibitor-based regimens
حسب: Alexander Englisch, وآخرون
منشور في: (2024-08-01)

Editorial: Understanding the heterogeneity and spatial brain environment of neurodegenerative diseases through conventional and future methods
حسب: Cui Li, وآخرون
منشور في: (2023-05-01)

Prevalence of COVID-19-associated symptoms during acute infection in relation to SARS-CoV-2-directed humoral and cellular immune responses in a mild-diseased convalescent cohort
حسب: Christian M. Tegeler, وآخرون
منشور في: (2022-07-01)

DNMT and HDAC inhibition induces immunogenic neoantigens from human endogenous retroviral element-derived transcripts
حسب: Ashish Goyal, وآخرون
منشور في: (2023-10-01)

The Human Leukocyte Antigen Class II Immunopeptidome of the SARS-CoV-2 Spike Glycoprotein
حسب: Michael D. Knierman, وآخرون
منشور في: (2020-12-01)

An open-source computational and data resource to analyze digital maps of immunopeptidomes
حسب: Etienne Caron, وآخرون
منشور في: (2015-07-01)

Integrated Immunopeptidomic and Proteomic Analysis of COVID-19 lung biopsies
حسب: Shanye Yin, وآخرون
منشور في: (2023-10-01)

AML-VAC-XS15-01: protocol of a first-in-human clinical trial to evaluate the safety, tolerability and preliminary efficacy of a multi-peptide vaccine based on leukemia stem cell antigens in acute myeloid leukemia patients
حسب: Susanne Jung, وآخرون
منشور في: (2024-10-01)

Designing a SARS-CoV-2 T-Cell-Inducing Vaccine for High-Risk Patient Groups
حسب: Hans-Georg Rammensee, وآخرون
منشور في: (2021-04-01)

Deciphering the HLA-E immunopeptidome with mass spectrometry: an opportunity for universal mRNA vaccines and T-cell-directed immunotherapies
حسب: Maya Weitzen, وآخرون
منشور في: (2024-09-01)

FusionVAC22_01: a phase I clinical trial evaluating a DNAJB1-PRKACA fusion transcript-based peptide vaccine combined with immune checkpoint inhibition for fibrolamellar hepatocellular carcinoma and other tumor entities carrying the oncogenic driver fusion
حسب: Christopher Hackenbruch, وآخرون
منشور في: (2024-03-01)

A combined immunopeptidomics, proteomics, and cell surface proteomics approach to identify immunotherapy targets for diffuse intrinsic pontine glioma
حسب: Kirti Pandey, وآخرون
منشور في: (2023-08-01)

Characterising the HLA‐I immunopeptidome of plasma‐derived extracellular vesicles in patients with melanoma
حسب: Caitlin Boyne, وآخرون
منشور في: (2024-03-01)

Personalized cancer vaccination is emerging: lessons learnt from renal cancer and challenges for broader application
حسب: Elke Schaeffeler, وآخرون
منشور في: (2025-04-01)

Leveraging Immunopeptidomics To Study and Combat Infectious Disease
حسب: Owen K. Leddy, وآخرون
منشور في: (2021-08-01)

Immunopeptidomics in the cancer immunotherapy era
حسب: Sutatip Pongcharoen, وآخرون
منشور في: (2024-07-01)

Immunopeptidomics in the Era of Single-Cell Proteomics
حسب: Rupert L. Mayer, وآخرون
منشور في: (2023-12-01)

COSMIC-based mutation database enhances identification efficiency of HLA-I immunopeptidome
حسب: Fangzhou Wang, وآخرون
منشور في: (2024-02-01)

Critical Review of Existing MHC I Immunopeptidome Isolation Methods
حسب: Alexandr Kuznetsov, وآخرون
منشور في: (2020-11-01)

Natural and cryptic peptides dominate the immunopeptidome of atypical teratoid rhabdoid tumors
حسب: Martin Ebinger, وآخرون
منشور في: (2021-10-01)

Mass spectrometry-based identification of a naturally presented receptor tyrosine kinase-like orphan receptor 1-derived epitope recognized by CD8+ cytotoxic T cells
حسب: Falk Heidenreich, وآخرون
منشور في: (2017-11-01)

IntroSpect: Motif-Guided Immunopeptidome Database Building Tool to Improve the Sensitivity of HLA I Binding Peptide Identification by Mass Spectrometry
حسب: Le Zhang, وآخرون
منشور في: (2022-04-01)

Accurate MHC Motif Deconvolution of Immunopeptidomics Data Reveals a Significant Contribution of DRB3, 4 and 5 to the Total DR Immunopeptidome
حسب: Saghar Kaabinejadian, وآخرون
منشور في: (2022-01-01)

Implications of MHC-restricted immunopeptidome in transplantation
حسب: Zhuldyz Zhanzak, وآخرون
منشور في: (2024-07-01)